MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Geron Corp

Chiusa

SettoreSettore sanitario

1.37 7.03

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.28

Massimo

1.38

Metriche Chiave

By Trading Economics

Entrata

3.5M

-16M

Vendite

9.4M

49M

Margine di Profitto

-33.394

Dipendenti

229

EBITDA

9.2M

-7.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+138.76% upside

Dividendi

By Dow Jones

Utili prossimi

6 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

46M

817M

Apertura precedente

-5.66

Chiusura precedente

1.37

Notizie sul Sentiment di mercato

By Acuity

19%

81%

339 / 371 Classifica in Healthcare

Geron Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 ott 2025, 20:45 UTC

Utili

Costco Wholesale Sales Climb in September, Early October

8 ott 2025, 20:12 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 ott 2025, 16:39 UTC

I principali Market Mover

Mining Shares Rise as Gold Prices Soar

8 ott 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen -- Market Talk

8 ott 2025, 23:43 UTC

Discorsi di Mercato

Gold Falls on Possible Profit-Taking -- Market Talk

8 ott 2025, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Finance Acquisition Using Internal Funds

8 ott 2025, 23:17 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 ott 2025, 23:16 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 ott 2025, 21:54 UTC

Discorsi di Mercato
Utili

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 ott 2025, 21:30 UTC

Discorsi di Mercato

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 ott 2025, 21:26 UTC

Discorsi di Mercato
Utili

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 ott 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 ott 2025, 19:15 UTC

Discorsi di Mercato

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 ott 2025, 19:01 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 ott 2025, 18:47 UTC

Discorsi di Mercato

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Will Remain a Publicly Traded Co >TASK

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 ott 2025, 18:45 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 ott 2025, 18:07 UTC

Discorsi di Mercato

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 ott 2025, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Energy & Utilities Roundup: Market Talk

8 ott 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 ott 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

8 ott 2025, 15:57 UTC

Discorsi di Mercato

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 ott 2025, 15:56 UTC

Discorsi di Mercato

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 ott 2025, 15:53 UTC

Discorsi di Mercato

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 ott 2025, 15:44 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 ott 2025, 15:44 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 ott 2025, 15:43 UTC

Acquisizioni, Fusioni, Takeovers

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 ott 2025, 15:42 UTC

Acquisizioni, Fusioni, Takeovers

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Geron Corp Previsione

Obiettivo di Prezzo

By TipRanks

138.76% in crescita

Previsioni per 12 mesi

Media 3.08 USD  138.76%

Alto 5 USD

Basso 1 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Geron Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

4

Acquista

2

Mantieni

1

Vendi

Sentiment

By Acuity

339 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat